BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7522008)

  • 1. Altered RNA turnover in carcinogenesis. The diagnostic potential of modified base excretion.
    Marvel CC; Del Rowe J; Bremer EG; Moskal JR
    Mol Chem Neuropathol; 1994; 21(2-3):353-68. PubMed ID: 7522008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of urinary excretion of modified nucleosides.
    Gehrke CW; Kuo KC; Waalkes TP; Borek E
    Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients.
    Xu G; Liebich HM; Lehmann R; Müller-Hagedorn S
    Methods Mol Biol; 2001; 162():459-74. PubMed ID: 11217356
    [No Abstract]   [Full Text] [Related]  

  • 4. Two approaches for determining the urinary excretion patterns of nucleosides--HPLC and CE.
    Xu G; Lu X; Zhang Y; Lu P; Di Stefano C; Lehmann R; Liebich H
    Se Pu; 1999 Mar; 17(2):97-101. PubMed ID: 12549143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.
    Heldman DA; Grever MR; Miser JS; Trewyn RW
    J Natl Cancer Inst; 1983 Aug; 71(2):269-73. PubMed ID: 6576186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control.
    Seidel A; Brunner S; Seidel P; Fritz GI; Herbarth O
    Br J Cancer; 2006 Jun; 94(11):1726-33. PubMed ID: 16685264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated urinary excretion of RNA catabolites as an early signal of tumor development in mice.
    Thomale J; Nass G
    Cancer Lett; 1982 Feb; 15(2):149-59. PubMed ID: 6178502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
    Waalkes TP; Gehrke CW; Zumwalt RW; Chang SY; Lakings DB; Tormey DC; Ahmann DL; Moertel CG
    Cancer; 1975 Aug; 36(2):390-8. PubMed ID: 1157009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS.
    Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E
    Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of urinary RNA catabolites in malignancies: cross-sectional and longitudinal studies.
    Müller J; Erb N; Heller-Schöch G; Lorenz H; Winkler K; Schöch G
    Recent Results Cancer Res; 1983; 84():317-30. PubMed ID: 6189161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased urinary levels of RNA catabolites in mice as early indicators for malignant growth.
    Thomale J; Luz A; Nass G
    Cancer Detect Prev; 1983; 6(1-2):73-6. PubMed ID: 6192923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of pseudouridine in patients with brain tumours.
    Manjula S; Aroor AR; Raja A; Rao S; Rao A
    Acta Oncol; 1993; 32(3):311-4. PubMed ID: 8323769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical analysis for cancer of the esophagus using monoclonal antibodies specific for modified nucleosides.
    Masuda M; Nishihira T; Itoh K; Mizugaki M; Ishida N; Mori S
    Cancer; 1993 Dec; 72(12):3571-8. PubMed ID: 8252470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrimidine nucleoside, pseudouridine, and modified nucleoside excretion by growing and resting fibroblasts.
    Uziel M; Selkirk JK
    J Cell Physiol; 1979 May; 99(2):217-22. PubMed ID: 457787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms.
    Patel D; Thompson MD; Manna SK; Krausz KW; Zhang L; Nilubol N; Gonzalez FJ; Kebebew E
    Clin Cancer Res; 2017 Sep; 23(17):5302-5310. PubMed ID: 28450405
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of urinary modified nucleosides and bases in rats with hepatomas and nephroblastomas.
    Clark I; MacKenzie JW; McCoy JR; Lin W
    Recent Results Cancer Res; 1983; 84():388-400. PubMed ID: 6302750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients.
    Xu G; Di Stefano C; Liebich HM; Zhang Y; Lu P
    J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):307-13. PubMed ID: 10517352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified nucleosides in urine: selective removal and analysis.
    Uziel M; Smith LH; Taylor SA
    Clin Chem; 1976 Sep; 22(9):1451-5. PubMed ID: 954194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High turnover rate of transfer RNA in tumor tissue.
    Borek E; Baliga BS; Gehrke CW; Kuo CW; Belman S; Troll W; Waalkes TP
    Cancer Res; 1977 Sep; 37(9):3362-6. PubMed ID: 884680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer RNA breakdown products in the urine of asbestos workers.
    Fischbein A; Sharma OK; Solomon S; Buschman F; Apell G; Kohn M; Selikoff IJ; Bekesi JG; Borek E
    Cancer Detect Prev; 1984; 7(4):247-52. PubMed ID: 6488216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.